Antagonists of toll-like receptor 3 for the treatment of metabolic and cardiovascular diseases

摘要

Toll-like receptor 3 (TLR3) antagonist antibodies, polynucleotides encoding TLR3 antagonist antibodies or fragments thereof, and methods for making and using the above substances are described.